Gsk Medical Affairs Jobs - 2022 | Indeed.com Start of main content What Date posted Posted By Remote Salary estimate Job type Education level Industry Location Company Post your resume and find your next job on Indeed! POSTER: Exploring Alternative Dosing Regimens of Single-Agent Belantamab Mafodotin on Safety and Efficacy in Patients With Relapsed or Refractory Multiple Myeloma (RRMM): DREAMM-14 (Encore), 4. excuses voor het ongemak. POSTER: Safety and Clinical Activity of Belantamab Mafodotin With Lenalidomide Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): DREAMM-6 Arm-A Interim Analysis, 3. 1. POSTER: ENGOT-EN6/NSGO-RUBY: A Phase 3, Randomized, Double-Blind, Multicenter Study of Dostarlimab + Carboplatin-Paclitaxel Versus Placebo + Carboplatin-Paclitaxel in Recurrent or Primary Advanced Endometrial Cancer (EC), 6. Singh AK, et al. 6. POSTER: Correlation of durability of response with best response or early discontinuation: A post hoc analysis of the GARNET endometrial cancer cohorts, 1. A Prospective Evaluation of Tolerability of Niraparib Dosing Based Upon Baseline Body Weight and Platelet Count: Blinded Pooled Interim Safety Data From the PRIMA/ENGOT OV26/GOG 3012 Study, 3. Real-World Benefits of Mepolizumab in Patients With Overlapping Allergic and Eosinophilic Endophenotypes: Post Hoc Analysis of REALITI-A by Omalizumab Eligibility. This effort supports employees by enhancing their strengths and addressing any development gaps through individual and group coaching and sponsorship. 2017;130(suppl 1): 1377. A Randomized, Cross-Over Study Comparing Critical and Overall Errors, Teaching Time, and Preference of the ELLIPTA Versus BREEZHALER Dry Powder Inhalers in Patients with Asthma. Patients with Uncontrolled Asthma Eligible for a Biologic. Expert Opin Ther Targets. Smith SG, Price R, Mollo MR, et al. PO2409, ASCEND-ID: Daprodustat is non-inferior to darbepoetin alfa in treating anemia in incident dialysis patients. Epigenetics. Impact of mepolizumab in patients with life-threatening asthma. Partner closely with MOC, medical affairs managers and 3rd party agencies to drive timely plan execution. Poster No. If you continue to see this Assessing Efficacy via Indirect Comparison of Single-Agent Belantamab Mafodotin (Belamaf; GSK2857916) in DREAMM-2 Versus STORM or MAMMOTH Studies in Relapsed/Refractory Multiple Myeloma (RRMM), 1. P824; Abstract A4313]. Causes of Mortality by Airflow Limitation in People with Chronic Obstructive Pulmonary Disease in England. [Poster No. Chronic obstructive pulmonary disease is associated with an increased risk of herpes zoster: a retrospective analysis of a United States claims database from 2013-2018. The recruitment process is key to starting off on the right foot. POSTER: Trial in Progress: Phase II Study of Niraparib and Dostarlimab for the Treatment of Germline or Somatic Homologous Recombination Repair Mutated Metastatic Pancreatic Cancer (Presentation Posted With Permission), 1. PLAIN LANGUAGE SUMMARY [HCP USE ONLY]: The DREAMM-2 Study: What Were the Effects of Belantamab Mafodotin in Patients With Multiple Myeloma and Reduced Kidney Function? Real World Evidence in Asthma: Pulmonary Function and Asthma Control in Respiratory Specialty Clinics in the US. Chronic Kidney Disease and Anemia Questionnaire (CKD-AQ): A Reliable and Sound PRO Measure for use in Patients with Anemia of CKD? PO0465, ASCEND-TD: A randomized, double-blind, active-controlled study of daprodustat administered three-times-weekly in hemodialysis patients. Bring your unwanted, unused, and expired medicines to the 24th@DEAHQQ's National Prescription Drug#TakeBackDayy between 10AM - 2PM. Sci Transl Med. PUBLICATION ONLY: Current Treatment Efficacy for Metastatic Soft Tissue Sarcoma: A Targeted Literature Review, 27. By bringing outstanding people together in an inclusive environment to do work that matters, we can impact the worlds health. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom. McCormack E, Adams KJ, Hassan NJ, et al. This site is intended for US Patients or Caregivers. 64), 5. Gsk Medical Affairs jobs Sort by: relevance - date 55 jobs EU Medical Affairs Lead, Hematology GSK 4.1 Brentford TW8 GSK3377794 is an adoptive cell therapy that uses genetically engineered autologous T cells expressing NY-ESO-1? POSTER: Incremental Healthcare Resource Utilization and Costs of Herpes Zoster in Patients with Psoriasis: A Retrospective Cohort Study. 1. 12. Asthma Control in Patients With Severe Eosinophilic Asthma Treated With Mepolizumab in Real-Life Settings: The Prospective, REALITI-A Study. Colleagues discuss issues that matter and explore different perspectives. Prevalence and Frequency of Eosinophil Testing in Patients with Asthma. A Phase 1 Dose Escalation Study of TSR-033, an Anti-LAG-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors, 3. 373. Bitte helfen Sie uns, Glassdoor zu schtzen, indem Sie besttigen, dass Sie Bogart M, Germain G, Lalibert F, et al. Insights From Allergy Practice (Poster No. POSTER: Safety and Clinical Activity of Belantamab Mafodotin With Pembrolizumab in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): DREAMM-4 Study, 5. Real-World Safety and Effectiveness of Fluticasone Furoate/Vilanterol in Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Post-Marketing Study in Korea. This information does not take the place of talking with your doctor. Real-World Impact of Systemic Corticosteroid (SCS) Exposure on Healthcare Resource Utilization (HRU) due to SCS-Related Complication among Patients with Asthma in the US? OX40 agonists and combination immunotherapy: putting the pedal to the metal. GSK is investigating a PI3K inhibitor, GSK2636771, in combination with enzalutamide, in PTEN-deficient metastatic castration-resistant prostate cancer (mCRPC). Symptom Burden in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy. Elaborating the Mechanism of PARP Synthetic Lethality in ATM Loss, 2. [Poster No. Daprodustat is not associated with an increased risk of cancer: results from the ASCEND-D and ASCEND-ND trials. ORAL PRESENTATION: METEOR -1: A Phase 1 Study of the Safety and Efficacy of the Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor GSK3326595 in Advanced Solid Tumors, 2. P805; Abstract A7742]. Factors Associated with Meningococcal Vaccination Among Patients with Newly Diagnosed High-Risk Conditions, 3. Wu AC, McMahon PM, Mendelsohn A, et al. 2. GSK Medical Affairs Efficacy and Safety of Mepolizumab in Hypereosinophilic Syndrome: a Phase III, Randomized, Placebo-Controlled Trial. J Clin Invest. Recent advances in targeting protein arginine methyltransferase enzymes in cancer therapy. #News for #investors and #media: Today we announced the proposed acquisition of @BELLUSHealth, a clinical stage biopharmaceutical company that further strengthens our specialty medicines and respiratory pipeline. 5. Gibbons D, Marijam A, Symons JM, et al. A Population Study. Mafodotin delivered to BCMA-expressing malignant cells inhibits microtubule polymerization, resulting in immune-independent apoptosis that is accompanied by release of markers of immunogenic cell death (ICD), which may contribute to an adaptive immune response. Oral presentation. MyOldMeds.com/blogrV. Singh, AK et al. 1. DREAMM-5 Platform Trial: Belantamab Mafodotin (Belamaf) in Combination With 4 Different Novel Agents in Patients With Relapsed/Refractory Multiple Myeloma (RRMM), 7. Waltham, MA: TESARO, Inc; 2019. POSTER: Pharmacokinetics and Safety Following a Single Oral Dose of Niraparib in Patients with Moderate Hepatic Impairment, 5. Once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) versus FF/VI in inadequately controlled asthma: the CAPTAIN study, 1. Genes Dev. POSTER: Patient-reported outcomes from the GARNET trial in patients with advanced or recurrent mismatch repair deficient colorectal cancer: a post hoc subgroup analysis, 11. Effects of Daprodustat on Hemoglobin and Quality of Life in Patients With CKD: Results of the ASCEND-NHQ Randomized, Double-blind, Placebo-controlled Trial, 4. Stimulator of interferon genes (STING) is a key adapter molecule that mediates sensing of cytosolic DNA and activates T-cell?dependent tumor immunity. Aydanos a proteger Glassdoor verificando que eres una persona real. Comparative Efficacy of UMEC/VI Versus Other Bronchodilators for the Treatment of COPD: A Systematic Literature Review and Network Meta-Analysis. GSK is committed to the discovery and development of new vaccines and oncology and hematology compounds that leverage patient-driven science to deliver improved outcomes for more patients. Anderson M, Drummond MB, Jain R, et al. Assessment of Peak Inspiratory Flow Rate in Patients With Chronic Obstructive Pulmonary Disease: Impact on Dose Delivery and Relationship With Response to Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy. Search job openings, see if they fit - company salaries, reviews, and more posted by GSK employees. To report suspected adverse reactions, please call us at www.vaers.hhs.gov to file a report, or call Impact of the COVID-19 Pandemic on Health Care Resource Utilization (HCRU) and Costs in Asthma in the United States: A Population-Based Study. Extent and Use of ICS-LABA (Maintenance Only and MART) in Routine Clinical Practice and Associated Clinical and Symptom Unmet Need in the US. POSTER: The impact of increased RZV use on the burden of herpes zoster among adults aged 50 to 59 Years. 2015;5:34, Aspeslagh S, Postel-Vinay S, Rusakiewicz S, Soria JC, Zitvogel L, Marabelle A. Comparative Efficacy of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Versus Other Triple Therapies for the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review and Network Meta-Analysis. Criner GJ, Barnes N, Brusselle G, et al. GlaxoSmithKline. 2018;9:1-15. doi:10.3389/fi mmu.2018.01821. Non-clinical tumor models reveal broad combination potential of ICOS agonist antibodies, April 10-15, 2021 and May 17-21, 2021 | Virtual, 1. 2. 3. 2016;126(7):2404-2411. Find a participating location near you atakebackday.dea.govjw #ppswgw#myoldmedsd#safedisposaladV, During the 2022 #TakeBackDay, the @DEAHQ collected over 324 tons of household medicines! Halpin DMG, Worsley S, Ismaila AS, et al. ur employees and our values are at the heart of everything we do. It inspires every one of us to do our best work. © 2022 GSK group of companies or its licensor. 1. Abstract Publication No. The most rewarding part about working at GSK is that I know I can count on my team and leadership for guidance and support. POSTER: Systematic literature review of prognostic factors associated with overall survival among advanced synovial sarcoma and myxoid/round cell liposarcoma subjects, 3. A prospective evaluation of tolerability of niraparib dosing based upon baseline body weight and platelet count: blinded pooled interim safety data from the PRIMA/ENGOT-OV26/GOGO3012 Study, 6.
